Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PADI4 | Q9UM07 | 8/20 | 0.63 |
| ▸ | PADI1 | Q9ULC6 | 7/20 | 0.63 |
| ▸ | PADI2 | Q9Y2J8 | 5/20 | 0.63 |
| ▸ | PADI3 | Q9ULW8 | 5/20 | 0.63 |
| ▸ | PDE4A | P27815 | 3/20 | 0.63 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.63 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.63 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.63 |
| ▸ | PADI6 | Q6TGC4 | 2/20 | 0.63 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.46 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | HPGDS | O60760 | 2/20 | 0.44 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1979577 | 1.00 | PADI4 (0.63) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL12598888 | 0.92 | PADI1 (0.59) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL19581174 | 0.89 | PADI4 (0.62) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL12560110 | 0.89 | PADI1 (0.56) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL1979695 | 0.89 | PADI4 (0.62) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL158990 | 0.88 | PADI1 (0.60) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL10946109 | 0.88 | PADI1 (0.60) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL1979621 | 0.87 | PADI4 (0.66) | PADI4PADI1PADI2PADI3PDE4A | |
| Hydrochloric Acid SCHEMBL29401072 | 0.86 | PADI1 (0.58) | PADI4PADI1PADI2PADI3PDE4A | |
| SCHEMBL10060236 | 0.84 | HDAC4 (0.51) | PADI4PADI1PADI2PADI3PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10309974-B2 | Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease | CEDARS-SINAI MEDICAL CENTER (US) | 2019-06-04 | — | — | US | claimed |
| US-20180136232-A1 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | CEDARS-SINAI MEDICAL CENTER (US) | 2018-05-17 | — | — | US | claimed |
| US-11980604-B2 | Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane | BOULDER BIOSCIENCE LLC (US) | 2024-05-14 | — | — | US | disclosed |
| US-20230104863-A1 | METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE | BOULDER BIOSCIENCE LLC | 2023-04-06 | — | — | US | disclosed |
| US-11529331-B2 | Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane | BOULDER BIOSCIENCE LLC (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220008387-A1 | METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE | BOULDER BIOSCIENCE LLC | 2022-01-13 | — | — | US | disclosed |
| EP-3761971-A1 | COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION | The University of Memphis Research Foundation (US) | 2021-01-13 | — | — | EP | disclosed |
| WO-2019173835-A1 | COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION | THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) | 2019-09-12 | — | — | WO | disclosed |
| US-10309974-B2 | Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease | CEDARS-SINAI MEDICAL CENTER (US) | 2019-06-04 | — | — | US | disclosed |
| US-20180136232-A1 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | CEDARS-SINAI MEDICAL CENTER (US) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230104863-A1 | METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE | PLAT, FGB, ADAMTS13 | PADI4 606/4885PADI1 750/4885PADI2 451/4885 |
| US-11980604-B2 | Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane | PLAT, FGB, ADAMTS13 | PADI4 575/4885PADI1 724/4885PADI2 427/4885 |
| US-20220008387-A1 | METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE | PLAT, FGB, ADAMTS13 | PADI4 606/4885PADI1 750/4885PADI2 451/4885 |
| US-11529331-B2 | Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane | PLAT, FGB, ADAMTS13 | PADI4 575/4885PADI1 724/4885PADI2 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.